In a rat model of acute pancreatitis, the infusion of anti-PAP1 antibodies worsened the pancreatic inflammatory response and PAP1 treatment prevented tumor necrosis factor (TNF)-α-induced Nuclear Factor kappa B (NF–κB) activation in macrophages [16]. The gene discussed is REG3A; the disease is acute pancreatitis.